DNTH icon

Dianthus Therapeutics

44 hedge funds and large institutions have $21.9M invested in Dianthus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.79M
2 +$2.54M
3 +$417K
4
Renaissance Technologies
Renaissance Technologies
New York
+$66.9K
5
CCM
Corsair Capital Management
New York
+$50.9K

Top Sellers

1 -$3.62M
2 -$1.38M
3 -$1.14M
4
TG
TCW Group
California
-$596K
5
Morgan Stanley
Morgan Stanley
New York
-$379K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.59M
2
$3.79M
3
$2.87M
4
$2.55M
5
$2.54M
6
$1.49M
7
$441K
8
$417K
9
$365K
10
$346K
11
$287K
12
$276K
13
$271K
14
$252K
15
$190K
16
$180K
17
$134K
18
$127K
19
$113K
20
$106K
21
$91.2K
22
$78.3K
23
$75.8K
24
$54.2K
25
$45.8K